VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 17 filers reported holding VANECK VECTORS ETF TR in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2023 | $385,299 | +15.2% | 12,425 | 0.0% | 0.04% | 0.0% |
| Q3 2023 | $334,357 | -17.5% | 12,425 | -7.7% | 0.04% | -15.4% |
| Q2 2023 | $405,431 | -9.5% | 13,465 | -2.8% | 0.05% | -14.8% |
| Q1 2023 | $448,048 | +12.9% | 13,850 | 0.0% | 0.06% | +7.0% |
| Q4 2022 | $396,941 | +17.1% | 13,850 | -1.4% | 0.06% | +7.5% |
| Q3 2022 | $338,886 | -11.9% | 14,050 | 0.0% | 0.05% | -5.4% |
| Q2 2022 | $384,689 | -28.6% | 14,050 | 0.0% | 0.06% | -17.6% |
| Q1 2022 | $538,818 | +19.7% | 14,050 | 0.0% | 0.07% | +21.4% |
| Q4 2021 | $450,022 | +6.8% | 14,050 | -1.7% | 0.06% | -5.1% |
| Q3 2021 | $421,421 | -8.8% | 14,300 | +5.1% | 0.06% | -7.8% |
| Q2 2021 | $462,128 | +70.3% | 13,600 | +62.9% | 0.06% | +56.1% |
| Q1 2021 | $271,375 | -9.8% | 8,350 | 0.0% | 0.04% | -24.1% |
| Q4 2020 | $300,767 | -8.0% | 8,350 | 0.0% | 0.05% | -18.2% |
| Q3 2020 | $326,986 | +4.9% | 8,350 | -1.8% | 0.07% | -5.7% |
| Q2 2020 | $311,780 | +53.6% | 8,500 | -3.5% | 0.07% | +34.6% |
| Q1 2020 | $202,982 | -22.2% | 8,810 | -1.1% | 0.05% | -7.1% |
| Q4 2019 | $260,885 | -17.5% | 8,910 | -24.7% | 0.06% | -23.3% |
| Q3 2019 | $316,113 | -7.9% | 11,835 | -11.9% | 0.07% | -11.0% |
| Q2 2019 | $343,399 | +11.9% | 13,435 | -1.8% | 0.08% | +6.5% |
| Q1 2019 | $306,818 | +3.8% | 13,685 | -2.3% | 0.08% | -8.3% |
| Q4 2018 | $295,471 | +10.9% | 14,010 | -2.6% | 0.08% | +37.7% |
| Q3 2018 | $266,410 | -19.5% | 14,385 | -3.0% | 0.06% | -25.6% |
| Q2 2018 | $330,969 | -3.8% | 14,835 | -5.3% | 0.08% | -8.9% |
| Q1 2018 | $344,207 | -5.4% | 15,660 | 0.0% | 0.09% | -6.2% |
| Q4 2017 | $363,938 | +1.1% | 15,660 | -0.2% | 0.10% | -8.6% |
| Q3 2017 | $360,128 | +84.4% | 15,685 | +77.3% | 0.10% | +61.5% |
| Q2 2017 | $195,298 | +0.2% | 8,845 | +3.5% | 0.06% | -3.0% |
| Q1 2017 | $194,911 | +32.2% | 8,545 | +21.3% | 0.07% | +21.8% |
| Q4 2016 | $147,381 | +34.4% | 7,045 | +69.8% | 0.06% | +27.9% |
| Q3 2016 | $109,685 | -4.6% | 4,150 | 0.0% | 0.04% | -4.4% |
| Q2 2016 | $114,997 | +1.9% | 4,150 | -26.5% | 0.04% | -2.2% |
| Q1 2016 | $112,831 | – | 5,650 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Memorial Sloan Kettering Cancer Center | 738,500 | $19,873,035 | 80.92% |
| New Harbor Financial Group, LLC | 1,680,752 | $45,229,033 | 14.96% |
| TORQ CAPITAL MANAGEMENT (HK) Ltd | 139,000 | $3,740,490 | 9.95% |
| Vanderbilt University | 1,360,540 | $36,612,131 | 9.45% |
| Eschler Asset Management LLP | 300,000 | $8,073,000 | 9.42% |
| New Harbor Financial Group, LLC | 1,027,300 | $27,644,643 | 9.15% |
| Guild Investment Management, Inc. | 139,333 | $3,749,454 | 6.28% |
| Monaco Asset Management SAM | 750,000 | $20,182,500 | 5.98% |
| STRATEGIC INVESTMENT MANAGEMENT, LLC | 132,460 | $3,867,832 | 4.74% |
| PCG Wealth Advisors, LLC | 264,614 | $7,120,782 | 4.67% |